Clinical Trial Update: Intravitreal Bevacizumab for Diabetic Retinopathy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating intravitreal bevacizumab for diabetic retinopathy was terminated, with the study status listed as terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Nonproliferative Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Severe Nonproliferative, Proliferative Diabetic Retinopathy | Phase 2, Phase 3 | Status: TERMINATED